Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · IEX Real-Time Price · USD
5.10
+0.05 (0.99%)
Apr 19, 2024, 2:07 PM EDT - Market open
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CAPR stock have an average target of 24, with a low estimate of 8.00 and a high estimate of 40. The average target predicts an increase of 370.59% from the current stock price of 5.10.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 1, 2024.
Analyst Ratings
The average analyst rating for CAPR stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +684.31% | Mar 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $8 | Buy | Initiates | $8 | +56.86% | Jan 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $40 | Strong Buy | Maintains | $18 → $40 | +684.31% | Oct 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +252.94% | Aug 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +252.94% | Mar 16, 2023 |
Financial Forecast
Revenue This Year
29.10M
from 25.18M
Increased by 15.59%
Revenue Next Year
121.74M
from 29.10M
Increased by 318.29%
EPS This Year
-0.98
from -0.83
EPS Next Year
0.10
from -0.98
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 31.5M | 194.3M | 287.5M | 197.9M |
| Avg | 29.1M | 121.7M | 124.9M | 192.3M |
| Low | 26.7M | 22.1M | 36.1M | 184.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 25.1% | 567.4% | 136.2% | 58.4% |
| Avg | 15.6% | 318.3% | 2.6% | 53.9% |
| Low | 5.9% | -24.2% | -70.4% | 47.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.79 | 1.51 | 3.78 | 1.76 |
| Avg | -0.98 | 0.10 | 0.79 | 1.71 |
| Low | -1.33 | -1.19 | -0.90 | 1.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | 3,700.9% | 122.4% |
| Avg | - | - | 697.4% | 116.1% |
| Low | - | - | - | 107.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.